Share this post

Graph of downward trend in novel CNV analysis publications when more of us are running NGSGraph of downward trend in novel CNV analysis publications when more of us are running NGS

In this 30 minute session, Sam Dougaparsad, Customer Success Manager, will discuss the current market approaches and strategies to Copy Number analysis in NGS which include a crowded field of algorithmic pipelines for CNV analysis. Sam will also review the universal CNV-calling strategy that NxClinical offers for targeted panels, exome sequencing, and whole genome sequencing.